Table 3 All-cause mortality rates in intact AAA patients with or without cancer
All-cause mortality | with cancer | without cancer | p-value | |||
|---|---|---|---|---|---|---|
Patients with intact AAA treated by EVAR or OSR (n = 11,785) | ||||||
30-day mortality | Censored | 1980 | (99.05) | 9676 | (98.88) | 0.4967 |
Event | 19 | (0.95) | 110 | (1.12) | ||
90-day mortality | Censored | 1931 | (96.60) | 9529 | (97.37) | 0.0537 |
Event | 68 | (3.40) | 257 | (2.63) | ||
Total mortality | Censored | 1575 | (78.79) | 8115 | (82.92) | <.0001 |
Event | 424 | (21.21) | 1671 | (17.08) | ||
Patients with intact AAA treated by EVAR (n = 7903) | ||||||
30-day mortality | Censored | 1560 | (99.11) | 6259 | (98.89) | 0.4534 |
Event | 14 | (0.89) | 70 | (1.11) | ||
90-day mortality | Censored | 1521 | (96.63) | 6150 | (97.17) | 0.2570 |
Event | 53 | (3.37) | 179 | (2.83) | ||
Total mortality | Censored | 1242 | (78.91) | 5221 | (82.49) | 0.0010 |
Event | 332 | (22.09) | 1108 | (17.51) | ||
Patients with intact AAA treated by OSR (n = 3882) | ||||||
30-day mortality | Censored | 420 | (98.82) | 3837 | (98.84) | 0.9719 |
Event | 5 | (1.18) | 45 | (1.16) | ||
90-day mortality | Censored | 410 | (96.47) | 3789 | (97.60) | 0.1053 |
Event | 15 | (3.53) | 93 | (2.40) | ||
Total mortality | Censored | 333 | (78.35) | 3227 | (83.13) | 0.0054 |
Event | 92 | (21.65) | 655 | (16.87) | ||